Logo

MAG Rumored to Be in Negotiations with Buyers

Dec 03, 1999
Premium

NEW YORK--Molecular Applications Group, which was rumored earlier this year to be struggling to stay afloat, is in negotiations to sell off its proprietary bioinformatics technologies to bidders including Celera and Affymetrix, according to a source close to one of the deals. Officials at Affymetrix and Celera said they would not comment on rumors, and MAG's acting CEO, Debra Yu, declined to comment.

Filed under

Informatics
Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.